Gala Global, Inc. (OTC:GLAG), a publicly-traded development firm specializing in equity investments, debt financing and mergers and acquisitions in the biotech industry, has completed the acquisition of a majority equity position in Controlled Environment Genomics Inc., an Akron, Ohio based start-up biotechnology company focused on the development and commercialization of computer controlled digital plant cloning incubators for use in the agricultural and biopharmaceutical industries.
Gala Global targets investments in companies commercializing biotechnologies, including indoor agriculture, molecular biology, genetics, and biopharmaceuticals.
“We are concentrating Gala Global’s focus on the biotech industry,” said Gala Global CEO Timothy Madden. “This allows us to expand our portfolio of companies now successfully commercializing technologies and services that create efficiencies and improvements, while simultaneously reducing production costs and improving economic growth in the industry.”
Said Madden: “Gala Global’s greatest potential exists in acquiring high-growth-rate companies that have intellectual property rights to commercially proven disruptive technologies, which are rapidly changing and expanding the biotech industry.”
Gala Global is now working with technology partner GenoBreeding Inc., on developing breeding tools such as molecular markers to enable productive plant breeding decisions and processes that achieve top-tier plant performance in a sustainable manner.
Another Gala Global technology partner is Controlled Environment Genomics, Inc. (CEG), an Akron, Ohio genomics company recently acquired by Gala Global. CEG specializes in digital plant gene sequencing, editing, and cloning technologies.
CEG’s state-of-the-art genomics technology enables GenoBreeding to digitally sequence the genomes of the most desirable plant varieties based on flavor and nutrition, so the desirable traits can be used to improve the most desirable commercial varieties with traits like increased yield, and quality, thus enhancing consumer demand for the product and increasing profitability.
GenoBreeding is also developing a proprietary digital genetic database that will be used as an online cloud based library of digitally sequenced genomes and phenotypic (chemical composition) information on all existing and new plant varieties.
CEG Inc. proprietary digital plant cloning technology will enable GenoBreeding’s geneticists to select the best plant varieties to hybridize, improving and increasing crop quality and yields, by combining the very best genetics, maximizing the variation of positive inherited characteristics in each variety.
Read the full press release here
Read More